Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders

Journal of Clinical Microbiology

Volumn 35, Issue 6, 1997, Pages 1612-1615

  Rowe, D T ^a   Qu, L ^a   Reyes, J ^a   Jabbour, N ^a   Yunis, E ^a   Putnam, P ^a   Todo, S ^a   Green, M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; EPSTEIN BARR VIRUS; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TARGET CELL; VIRUS DETECTION; VIRUS GENOME; VIRUS SHEDDING;

HUMAN HERPESVIRUS 4;

EID: 0030927507     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.6.1612-1615.1997     Document Type: Article

References (31)

1. Bieber, C. P., R. L. Heberling, S. W. Jamieson, P. E. Oyer, M. R. Warnke, A. Saemundesen, G. Klein, W. Henle, and E. Stinson. 1984. Lymphoma in cardiac transplant recipients associated with cyclosporine A, prednisone and anti-thymocyte globulin (ATG), p. 309-330. In D. T. Purtilo (ed.), Immune deficiency and cancer. Plenum Press, New York, N.Y.
2. Cen, H., M. C. Breinig, R. W. Atchison, M. Ho, and J. L. C. McKnight. 1991. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J. Virol. 65:976-980.
3. Chen, F., J.-Z. Zhou, L. di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
4. Craig, E. F., M. L. Gulley, and P. M. Banks. 1993. Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 99:265-276.
5. Delecluse, H.-J., E. Kremmer, J.-P. Rouault, C. Cour, G. Bornkamm, and F. Berger. 1995. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am. J. Pathol. 146:113-120.
6. de The, G., A. Geser, N. E. Day, P. M. Tukei, E. H. Williams, D. P. Beri, P. G. Smith, A. G. Dean, G. W. Bornkamn, P. Feorino, and W. Henle. 1978. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274:756-761.
7. Gutierrez, M. I., K. Bhatia, and I. Magrath. 1993. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Leuk. Res. 17: 285-289.
8. Hanto, D. W., K. J. Gajl-Peczalska, G. Frizzera, D. C. Arthur, H. H. Balfour, K. McClain, R. L. Simmons, and J. S. Najarian. 1983. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B cell lymphoproliferative disease occurring after renal transplantation. Ann. Surg. 198:356-369.
9. Kenagy, D. N., Y. Schlesinger, K. Weck, J. N. Ritter, M. M. Gaudreault-Keener, and G. A. Storch. 1995. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 547-554.
10. Khanna, R., S. R. Burrows, and D. J. Moss. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:387-405.
11. Klein, G. 1983. Specific chromosomal translocations and the genesis of B cell derived tumors in mice and men. Cell 32:311-315.
12. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791-793.
13. Kovalic, D., J. H. Kwak, and B. Weisblum. 1991. General method for direct cloning for DNA fragments generated by the polymerase chain reaction. Nucleic Acids Res. 19:4560-4561.
14. Lager, D. J., H. Burgart, and D. D. Slagel. 1993. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder. Mod. Pathol. 6:42-46.
15. Leibowitz, D., and E. Kieff. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. N. Fields, D. M. Knipe, et al. (ed.), Fields virology. Raven Press, New York, N.Y.
16. Masucci, M. G. 1993. Viral immunopathology of human tumors. Curr. Opin. Immunol. 5:693-700.
17. Nalesnik, M. A., R. Jaffe, T. E. Starzl, et al. 1988. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol. 133:173-192.
18. Penn, I., W. Hammond, L. Brettschneider, and T. E. Starzl. 1989. Malignant lymphomas in transplantation patients. Transplant. Proc. 1:106-112.
19. Preiksaitis, J. K., F. Diaz-Mitoma, F. Mirzayans, S. Roberts, and D. H. Tyrrell. 1992. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J. Infect. Dis. 166:986-994.
20. Randhawa, P. S., R. Jaffe, M. Demetris, M. Nalesnik, T. E. Starzl, Y. Y. Chen, and L. M. Weiss. 1991. The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am. J. Pathol. 138:1027-1033.
21. Rea, D., C. Fourcase, V. Leblond, M. Rowe, I. Joab, L. Edelman, M.-O. Bitker, I. Gandjbakhich, C. Suberbielle, J.-P. Farcet, and M. Raphael. 1994. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 58:317-324.
22. Riddler, S. A., M. C. Breinig, and J. L. C. McKnight. 1994. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 972-984.
23. Rooney, C. M., S. K. Loftin, M. S. Holladay, M. K. Brenner, R. A. Krance, and H. E. Heslop. 1995. Early identification of Epstein-Barr virus associated posttransplantation lymphoproliferative disease. B. J. Haematol. 89:98-103.
24. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2712-2722.
25. Starzl, T. E., K. A. Porter, S. Iwatsuki, J. T. Rosenthal, B. W. Shaw, R. W. Atchison, M. A. Nalesnik, M. Ho, B. P. Griffith, T. R. Hakala, R. L. Hardesty, and R. Jaffe. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet i:583-587.
26. Swerdlow, S. H. 1992. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20:373-385.
27. Thorley-Lawson, D. A., and K. P. Mann. 1985. Early events in EBV infection provide a model for B cell activation. J. Exp. Med. 162:45-57.
28. Thorley-Lawson, D. A. 1988. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim. Biophys. Acta 948:263-286.
29. Tierney, R. J., N. Stevens, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
30. Wagner, H. J., G. Bein, A. Bitsch, and H. Kirchner. 1992. Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 30:2826-2829.
31. Weiss, L. M., and L. A. Movahed. 1989. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am. J. Pathol. 134:651-659.